1-(4-FORMYLPHENYL)-1-OXO-5,8,11,14-TETRAOXA-2-AZAHEPTADECAN-17-OIC ACID, 95%, 250mg

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-(methylamino)piperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 98.0%, 100mg

4-Chloro-1,3-dioxolan-2-one, 90.0%, 100g

tert-Butyl (1R*,4R*)-4-[(cyclopropylmethyl)amino]-cyclohexylcarbamate, 1g

Choline Chloride>98.0%(T)25g

Long working distance plan phase 10x/0.25 IOS objective, working distance 7.45 mm

2-Isopropyl-5-methyl-2H-pyrazol-3-ylamine, 95.0%, 500mg

2-Hexyl-4-pentynoic Acid>95.0%(T)25g

4-Bromo-2-cyclopropylthiazole, 97%, 5g

Incubator Heratherm Protocol series General Protocol with natural convection, 117 l, IGS100, 1 Piece

5-(4-Butyl-phenyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 1g

Eosin Y solution, 500 ml

rac 1-Methyl-pyrrolidine-2-carbonitrile, 95.0%, 5g